Navigation Links
Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference
Date:11/1/2007

SINGAPORE -- To mark its 100th year of advancing cancer research, the American Association for Cancer Research is holding Centennial Conferences in North America, Europe, and Asia. The AACR has teamed with the Genome Institute of Singapore and Singapores Agency for Science, Technology and Research (A*STAR) to hold the first of these conferences from November 4 to 8 in Singapore: the AACR Centennial Conference on Translational Cancer Medicine: From Technology to Treatment.

The conference will convene cancer research experts, scientists in training, and physicians from academia, industry, and government in Singapore to discuss emerging technologies that will enable the translation of laboratory discoveries into the practice of cancer medicine.

This meeting will foster the necessary dialogue to speed application of breakthrough laboratory discoveries to the practice of medicine. Translational cancer medicine provides the tools to build the connections needed to move practical knowledge from the laboratory to drug development to patient care, said William N. Hait, M.D., Ph.D., president of AACR, co-chairperson of the conference and senior vice president and head, worldwide hematology oncology research and development at Johnson and Johnson. By hosting this meeting in Singapore, not only are we expanding this discussion across international lines, but we are also highlighting the unique strengths of our Singapore colleagues as well as the challenges faced by researchers in response to the needs of Asian patients.

Specific topics will include advanced studies in cancer biology, genomics and molecular targets for future cancer drugs as well as the latest imaging, and high-throughput approaches to cancer detection, diagnosis, and treatment. The meeting will also explore questions specific to the region, such as the constraints and opportunities of cancer care delivery in Asia, and how best to tailor cancer treatment to the genetic profile
'/>"/>

Contact: Staci Vernick Goldberg
staci.goldberg@aacr.org
267-646-0616
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. PCR emerging as a promising technique for Diagnosing Urinary Tuberculosis
2. HIV Virus Emerging Drug Resistant In UK, Prompting Fear Of A Second Epidemic
3. Tamil Nadu Emerging As Model State In Public Health Care: Governor
4. Emerging Therapies for Skin Cancer Treatment
5. Emerging Research Heralds New Era of Breast Cancer Management
6. Emerging from the shadows of Breast Cancer
7. Law Emerging in US for Generic Versions of Biotech Medicine
8. Resistance Already Emerging in First Months of Treatment Despite Viral Load Decline
9. FDA Announces Audio Broadcasts on Emerging Drug Safety Information
10. Nutrient-rich Dairy Beverages an Emerging Market
11. Fire Ants are Emerging Nuisance for Virginians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... 2015 , ... AlignLife Office Coordinator Heather Pugh earned the position ... patients at this natural health care center in Winamac. , "Oftentimes patients are in ... role is vital to our approach because we want to focus on the patient ...
(Date:8/1/2015)... ... August 01, 2015 , ... Western University of Health Sciences’ ... comprises a growing percentage of U.S. physicians, and reflects the diversity of the ... of the message delivered by John W. Becher, DO, president of the American ...
(Date:8/1/2015)... ... 2015 , ... The condition where veins are enlarged and gnarled is known ... and discomfort. Those who spend a lot of time on their feet and standing ... doing what it can to create awareness and provide a cure in observance of ...
(Date:8/1/2015)... ... August 01, 2015 , ... Tina Wilcoxson, owner of Freeport Maine’s Royal River ... honor by the National Retail Federation, the largest retail trade association in the world, ... Maine business owners to be named as such. According to the NRF’s website, Retail ...
(Date:8/1/2015)... ... August 01, 2015 , ... Professional ... portfolio company has acquired Premier Physical Therapy & Wellness (“Premier”) — with 13 ... state-of-the-art clinics. , “Our acquisition of Premier Physical Therapy & Wellness solidifies Professional ...
Breaking Medicine News(10 mins):Health News:New Patient Advocate Enhances Natural Health Care 2Health News:COMP-Northwest Welcomes Class of 2019 2Health News:COMP-Northwest Welcomes Class of 2019 3Health News:COMP-Northwest Welcomes Class of 2019 4Health News:COMP-Northwest Welcomes Class of 2019 5Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Local Retail Advocate Wins National Recognition 2Health News:Professional Physical Therapy Now Largest Outpatient Physical Therapy Provider in Northeast With Acquisition of Premier Physical Therapy & Wellness 2
... U.S. Food and Drug Administration (FDA) today cleared for ... cancer returning //within five to 10 years after a ... test that profiles genetic activity. ,The MammaPrint ... whether existing cancer will metastasize (spread to other parts ...
... on releasing a new line of digital insulin pens for ... thought //to help patients manage their insulin dosages and avoid ... needle, was unveiled today at Battelle. It is the newest ... Indianapolis-based pharmaceutical company. ,The device, called the ...
... major findings of a new study, children who sleep ... less, and they //are less likely than their counterparts ... this new study were published in the January/February 2007 ... ,Conducted by researchers at Northwestern University, the study looked ...
... three-member medical board, who examined former union coal minister Shibu ... of the Jharkhand Mukti Morcha (JMM) chief to provide him ... ,Considering the swelling in his legs that portends serious heart ... to keep Soren in Dumka, which do not have advanced ...
... developed at Brown University, promises to improve our understanding of ... tomography, or CT, delivers detailed 3-D images, but CT scanners ... that uses X-rays to view objects, can produce moving images ... surgeon trying to figure out the best way to repair ...
... aims to solve the problem of dosage variance and ... for children.//, ,The new Watchhaler product from Activaero ... appeal to kids, with vivid colours and an ‘animal-like ... used in combination with conventional metered dose inhalation devices ...
Cached Medicine News:Health News:FDA Clears Breast Cancer Specific Molecular Prognostic Test 2Health News:FDA Clears Breast Cancer Specific Molecular Prognostic Test 3Health News:Childhood Obesity Linked With Sleep 2Health News:New Inhaler is Child's Play 2Health News:New Inhaler is Child's Play 3
(Date:7/30/2015)... Ohio, July 30, 2015 Mettler-Toledo International Inc. ... for 2015.  Provided below are the highlights: ... quarter compared with the prior year. Reported sales decreased ... the quarter. , Net earnings per diluted share ... the prior-year period. Adjusted EPS was $2.80 , ...
(Date:7/30/2015)... 30, 2015  ResMed Inc. (NYSE: RMD ) ... 2015.  Revenue for the quarter was $453.1 million, a ... 30, 2014 (a 17 percent increase on a constant ... the quarter ended June 30, 2014.  Diluted earnings per ... quarter ended June 30, 2014.  The ...
(Date:7/30/2015)... , July 30, 2015  Today we bring you a special edition of ... to remind you about some of our Medicare resources and continue highlighting the success ... Check out our latest infographics and videos here: ... ... ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3
... Nov. 3, 2010 DURECT Corporation (Nasdaq: DRRX ... September 30, 2010. Total revenues were $8.1 million for the ... for the three months ended September 30, 2009; revenues in ... of certain excipients used in REMOXY® to King Pharmaceuticals in ...
... Biotechnology, Inc. (OTC Bulletin Board: CSBR ), a ... tumor specific data to enhance the value of oncology drugs, ... Qualifying Therapeutic Discovery Project ("QTDP"). The QTDP was enacted as ... 2010. About Champions Biotechnology, Inc. Champions Biotechnology, ...
Cached Medicine Technology:DURECT Corporation Announces Third Quarter 2010 Financial Results 2DURECT Corporation Announces Third Quarter 2010 Financial Results 3DURECT Corporation Announces Third Quarter 2010 Financial Results 4DURECT Corporation Announces Third Quarter 2010 Financial Results 5DURECT Corporation Announces Third Quarter 2010 Financial Results 6DURECT Corporation Announces Third Quarter 2010 Financial Results 7Champions Biotechnology Awarded $1.46 million in Grants 2
AccuSign DOA Series tests include tests for Amphetamines, Barbituates, Benzodiazepines, Cocaine, Methadone, Methamphetamines, Nicotine (Cotinine), Opiates, Phencyclidine, THC, Tricyclic Antidepressan...
... of abuse tests are highly accurate in detecting ... cut-off as confirmed by GC/MS testing. This assay ... alternative method (such as GC/MS) must be used ... judgment should be applied to any drug of ...
AccuSign® DOA Series Opiates Test...
... The QuickScreen™ At Home Drug Test is ... the FDA for home use. The kit includes ... easy to read instructions, a handbook with frequently ... ship the sample to the laboratory if the ...
Medicine Products: